Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Covington Represents Boston Children's Hospital in Royalty Monetization

June 20, 2018

NEW YORK—Covington advised Boston Children's Hospital in its monetization of a portion of its royalties relating to Vonvendi, a recombinant drug used to treat a common bleeding disorder called von Willebrand disease. The purchaser, Barings Alternative Investments, part of Barings LLC, on behalf of institutional investors, paid $51.5 million.

Boston Children’s Hospital plans to invest the proceeds of the royalty monetization into pediatric medical research.

The Covington team consisted of John Gourary, Rachel Beller, and Brianna Bloodgood (corporate); Natalie Derzko (intellectual property); and Ansgar Simon (tax).

Share this article: